Full-Time

PET/CT Technologist

Confirmed live in the last 24 hours

Akumin

Akumin

201-500 employees

Outsourced radiology and oncology services provider

No salary listed

Junior

Lexington, KY, USA

Category
Diagnostics & Laboratory Professionals
Medical, Clinical & Veterinary
Requirements
  • High School Diploma or equivalent experience required; Associate’s Degree or equivalent experience preferred.
  • Certification in Nuclear Medicine by the NMTCB or ARRT (N) required.
  • State license, as required.
  • CPR certification required.
  • As applicable, valid state driver’s license.
  • 1-2 years’ experience in Nuclear Medicine procedures and studies preferred.
  • Ability to work at several locations.
  • Strong customer service skills.
  • Organizational and multi-tasking skills.
  • Basic knowledge of computer applications and programs.
  • Local travel may be required.
  • The COVID-19 vaccination is/may be a condition of employment.
  • All candidates who accept an offer for employment will be required to successfully complete a pre-employment background check and drug screen as a condition of employment.
Responsibilities
  • Responsible for patient safety including pre-screening for contraindications, aseptic injection technique, etc. and radiation safety/regulations, including proper documentation and technique when working with radioactive materials/patients.
  • Produces high quality diagnostic images.
  • Effectively communicates with customers and/or radiologists.
  • Trains new technologists and/or PC's.
  • Trouble-shoots the scanner, coach and peripheral equipment (including: monitors, PACS, coils, etc.).
Desired Qualifications
  • 1-2 years’ experience in Nuclear Medicine procedures and studies preferred.

Akumin provides outsourced radiology and oncology services to hospitals, health systems, and physician groups throughout the United States. Their services include fixed-site outpatient diagnostic imaging, which is available at various imaging locations, as well as outpatient radiology and oncology services. Akumin partners with approximately 1,000 hospitals and health systems across 47 states to deliver these essential healthcare services. What sets Akumin apart from its competitors is its extensive network and ability to offer a wide range of imaging and oncology solutions tailored to the needs of healthcare providers. The company's goal is to enhance patient care by providing reliable and accessible diagnostic and treatment services.

Company Size

201-500

Company Stage

IPO

Headquarters

Plantation, Florida

Founded

1997

Simplify Jobs

Simplify's Take

What believers are saying

  • Financial restructuring with Stonepeak strengthens Akumin's balance sheet and liquidity.
  • Growing demand for outpatient imaging services supports Akumin's business model.
  • Partnerships with tech firms offer opportunities to integrate advanced imaging analytics.

What critics are saying

  • Increased competition from private equity-backed healthcare firms may impact market share.
  • Potential regulatory delays could extend restructuring timelines and increase costs.
  • Transition to a private company may reduce transparency and investor confidence.

What makes Akumin unique

  • Akumin focuses on outpatient imaging services, aligning with cost-effective healthcare trends.
  • The company integrates AI to enhance diagnostic accuracy and workflow efficiency.
  • Akumin's emphasis on value-based care aligns with industry shifts towards quality outcomes.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Flexible Work Hours

Company News

Cantech Letter
Oct 23rd, 2023
Akumin likely won’t get a better offer than Stonepeak, Clarus says

The deal from private equity firm Stonepeak to acquire Akumin likely won’t be topped, says Clarus Securities analyst Noel Atkinson.

PR Newswire
Oct 20th, 2023
Akumin Inc. Reaches Agreement With Stonepeak To Become A Private Company

Financial restructuring to fortify balance sheet and provide liquidity runway for next stage of growthApprovals received from key stakeholders across capital structure; transaction will be implemented through prepackaged court-supervised process; Expected to obtain court approval within the next 45 daysBusiness will continue to operate as usual without interruption; trade creditors, employees, and other partners expected to continue to be paid in ordinary coursePLANTATION, Fla., Oct. 20, 2023 /PRNewswire/ - Akumin Inc. ("Akumin" or the "Company") (NASDAQ: AKU) (TSX: AKU) announced today that it has reached an agreement with Stonepeak, a leading alternative investment firm specializing in infrastructure and real assets, and the Company's stakeholders on the terms of a financial restructuring that will substantially improve the Company's balance sheet and provide ample liquidity to position Akumin for future success. The contemplated transaction will result in Akumin no longer being publicly listed.To effect the transaction in a timely and efficient manner, the Company and certain of its subsidiaries will commence prepackaged chapter 11 cases in the Southern District of Texas. The Company expects to obtain court approval of the transaction within the next 45 days and complete the transaction after receiving certain regulatory approvals. Throughout the process, Akumin's operations are expected to continue as normal